Edythe D London, Ph.D.

Trials

Studies that name Edythe D London, Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:24 UTC. Open this list on ClinicalTrials.gov

• Early Ph1
  NCT04553263 · Relapse Prevention in Stimulant Use Disorder

  University of California, Los Angeles · withdrawn · Stimulant Use, Relapse, Cognitive Function · principal investigator
• Ph1
  NCT03059563 · Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users

  University of California, Los Angeles · terminated · Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse · principal investigator
• Ph1
  NCT01359709 · Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking

  University of California, Los Angeles · completed · Cigarette Smoking Behavior · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
  R21DA042347 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Edythe Danick London · fiscal years 2017 to 2018
  Named on NCT03059563